Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,664
Closed -$319K 604
2023
Q4
$319K Sell
6,664
-8,688
-57% -$414K 0.01% 376
2023
Q3
$785K Sell
15,352
-3,250
-17% -$172K 0.03% 192
2023
Q2
$1.07M Sell
18,602
-3,322
-15% -$194K 0.04% 147
2023
Q1
$1.32M Sell
21,924
-6,889
-24% -$421K 0.04% 126
2022
Q4
$1.69M Buy
28,813
+725
+3% +$45.9K 0.06% 119
2022
Q3
$1.6M Sell
28,088
-5,289
-16% -$308K 0.06% 104
2022
Q2
$1.81M Buy
33,377
+14,922
+81% +$866K 0.07% 120
2022
Q1
$1.06M Buy
18,455
+12,133
+192% +$620K 0.04% 161
2021
Q4
$299K Buy
+6,322
New +$288K 0.01% 249
2020
Q3
Sell
-505
Closed -$14K 312
2020
Q2
$14K Buy
505
+99
+24% +$2.58K ﹤0.01% 468
2020
Q1
$10K Buy
406
+311
+327% +$8.55K ﹤0.01% 362
2019
Q4
$3K Buy
95
+17
+22% +$450 ﹤0.01% 499
2019
Q3
$2K Buy
+78
New +$2.25K ﹤0.01% 632

Other funds holding CTVA

Balentine LLC's CTVA Position: Q1 2024 in Review

Balentine LLC sold out of Corteva (CTVA) in Q1 2024, closing a stake of 6,664 shares — an estimated $319K sold.

Balentine LLC first reported a position in CTVA in Q3 2019 and held it in 13 quarters. The position peaked at $1.81M in Q2 2022. 1,260 funds tracked by Wall St. Rank hold CTVA as of Q1 2024.

  • Balentine LLC reported no remaining Corteva position as of Q1 2024 after selling out during the quarter.
  • Balentine LLC sold 6,664 Corteva shares in Q1 2024, an estimated $319K.
  • Balentine LLC first reported a position in Corteva in Q3 2019 and held it in 13 quarters.
  • Balentine LLC's Corteva position peaked at $1.81M in Q2 2022.
  • 1,260 funds tracked by Wall St. Rank held Corteva as of Q1 2024.

Based on Balentine LLC's 13F filing for Q1 2024, filed 15 May 2024.